WO2001045577A2 - Intervertebral disc treatment devices and methods - Google Patents

Intervertebral disc treatment devices and methods Download PDF

Info

Publication number
WO2001045577A2
WO2001045577A2 PCT/US2000/042610 US0042610W WO0145577A2 WO 2001045577 A2 WO2001045577 A2 WO 2001045577A2 US 0042610 W US0042610 W US 0042610W WO 0145577 A2 WO0145577 A2 WO 0145577A2
Authority
WO
WIPO (PCT)
Prior art keywords
disc
growth factor
tissue growth
bmp
members
Prior art date
Application number
PCT/US2000/042610
Other languages
French (fr)
Other versions
WO2001045577A3 (en
WO2001045577A9 (en
Inventor
William F. Mckay
Original Assignee
Sdgi Holdings, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK00992392T priority Critical patent/DK1244388T3/en
Priority to CA002392721A priority patent/CA2392721C/en
Priority to EP00992392A priority patent/EP1244388B1/en
Priority to DE60033055T priority patent/DE60033055D1/en
Priority to AU43099/01A priority patent/AU774481B2/en
Priority to JP2001546319A priority patent/JP4672947B2/en
Application filed by Sdgi Holdings, Inc. filed Critical Sdgi Holdings, Inc.
Publication of WO2001045577A2 publication Critical patent/WO2001045577A2/en
Priority to US10/165,347 priority patent/US20020173851A1/en
Publication of WO2001045577A3 publication Critical patent/WO2001045577A3/en
Publication of WO2001045577A9 publication Critical patent/WO2001045577A9/en
Priority to US10/990,823 priority patent/US7318840B2/en
Priority to US11/877,235 priority patent/US8349012B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/441Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4603Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
    • A61F2/4611Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30075Properties of materials and coating materials swellable, e.g. when wetted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/3023Three-dimensional shapes cylindrical wedge-shaped cylinders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/4435Support means or repair of the natural disc wall, i.e. annulus, e.g. using plates, membranes or meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/444Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2002/4495Joints for the spine, e.g. vertebrae, spinal discs having a fabric structure, e.g. made from wires or fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4603Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
    • A61F2002/4625Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use
    • A61F2002/4627Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use with linear motion along or rotating motion about the instrument axis or the implantation direction, e.g. telescopic, along a guiding rod, screwing inside the instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0061Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00377Fibrin

Definitions

  • the present invention relates generally to devices and methods for restoring function to the spine. Specifically, the invention relates., to devices and methods for treating a damaged intervertebral disc while retaining the annulus fibrosis of the disc and, advantageously, stimulating tissue formation to restore function to the original disc structure.
  • Back pain affects millions of people and is a common cause of disability for the middle-aged working population. A frequent cause of back pain is rupture or degeneration of intervertebral discs.
  • Intervertebral discs located between the endplates of adjacent vertebrae, stabilize the spine, distribute forces between vertebrae, and cushion vertebral bodies.
  • An intervertebral disc includes the annulus fibrosus, a structure that surrounds and confines an inner component, the nucleus pulposus.
  • the annulus fibrosis is composed of a ring of collagen fibers and fibrocartilage embedded in a generally amorphous base substance.
  • the nucleus pulposus is comprised of a mucoid material containing mainly glycoproteins and some collagen.
  • the annulus fibrosus prevents the nucleus pulposus from protruding outside the disc space and also resists torsional and bending forces applied to the disc. Intervertebral discs may be displaced or damaged due to disease or aging.
  • Disruption of the annulus fibrosus can allow the nucleus pulposus to protrude into the vertebral canal or intervertebral foramen, a condition known as a herniated or slipped disc.
  • a rupture in the annulus fibrosis can allow the escape of nucleus pulposus components.
  • the extruded nucleus pulposus may press on a spinal nerve, ⁇ which may result in nerve damage, pain, numbness, muscle weakness and paralysis.
  • the disc space height will be reduced, leading to instability of the spine, decreased mobility and pain.
  • excessive movement of the spinal segments caused by the disc space height reduction could weaken the annulus fibrosus and, in certain cases, tear it.
  • the present invention relates to methods and devices for repairing an intervertebral disc which include promoting synthesis of tissue components, such as nucleus pulposus and/or annulus fibrosus components, of the disc.
  • the present invention provides a device which can be used to promote the synthesis of disc components in vivo to treat intervertebral discs.
  • a device for treating an intervertebral disc of a vertebrate while retaining an intact annulus fibrosis the device including a compressible fibrous body configurable to a compressed state for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis.
  • the body is also configurable to an expanded state to reside within the disc cavity and have a dimension greater than the opening so as to resist expulsion from the opening.
  • the body incorporates an effective amount of an active agent, such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells) , such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
  • an active agent such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells) , such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
  • an intervertebral disc treatment device including a fibrous body sized for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis.
  • the body is formed of fibers having coated thereon a solid carrier matrix incorporating a substance for promoting tissue growth.
  • the body of the device may be partially or completely bioresorbable .
  • the body may be sized and configured to provide temporary or permanent prosthetic function, by being dimensioned to participate in the distribution of compressive loads between adjacent vertebral bodies.
  • the body may be adapted to physically maintain a space in the disc as new tissue is generated, and provide a substrate ' for tissue ingrowth which locks the implant in place ar.d reinforces regenerated tissues to help maintain disc space height.
  • the body may be non-prosthetic, while delivering a substance for promoting tissue growth in the disc structure.
  • the device can be dimensioned, or can be formed of a material having compressive properties, such that it does not participate in the distribution of loads between the adjacent vertebral bodies. Nonetheless, such a non-prosthetic body may deliver the tissue growth substance so as to enhance the function or integrity of the disc structure.
  • Another feature of the invention provides an intervertebral disc repair apparatus that has a disc treatment device as described above in combination with a delivery apparatus.
  • the delivery apparatus is adapted to retain and selectively release the treatment device into the disc cavity, and may for example include a member having a proximal end, a distal end and a lumen extending longitudinally therethrough.
  • the disc repair device is disposed within the lumen of the apparatus.
  • the delivery apparatus is adapted to translate the disc repair device distally through the lumen, through an opening in the annulus fibrosis, and into the disc cavity.
  • methods for treating a disc having an annulus fibrosis having an opening therein which methods include providing a body configured for passage through the opening and for blocking effluence from the opening once positioned within the disc cavity. The body is passed through the opening and into the disc cavity, so as to block effluence from the opening.
  • a tissue growth composition is also provided within the disc cavity, either as a component of the body or separately.
  • FIG. 1 is a perspective view of a disc treatment device of the present invention.
  • FIG. 2 is an enlarged, cross-sectional view of the device of FIG. 1 taken along a vertical plane through line 2-2 and viewed in the direction of the arrows.
  • FIG. 3 is a perspective view of a further disc treatment device of the present invention having an annular ring shape.
  • FIG. 4 is a perspective view of a further disc treatment ' device of the present invention.
  • FIG. 5 is a side cross-sectional view illustrating the disc repair device shown in FIG. 1 positioned within an intervertebral disc.
  • FIG. 6 is a superior view of the disc treatment device of FIG. 1 positioned in the disc cavity of an intervertebral disc.
  • FIG. 7 is a superior view of the disc treatment device of FIG. 3 positioned in the disc cavity of an intervertebral disc.
  • FIG. 8 is a superior view of the disc treatment device of FIG. 4 positioned in the disc cavity of an intervertebral disc.
  • FIG. 9 is a superior view illustrating two disc treatment devices positioned in the disc cavity of an intervertebral disc, and wherein an opening in the annulus fibrosis is sealed with a sealant composition.
  • FIG. 10 is a superior view illustrating first and second disc treatment devices positioned within the disc cavity of an intervertebral disc, wherein one functions to seal a rupture in the annulus fibrosis.
  • FIG. 11 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 3 in a compressed conformation in the lumen of a delivery apparatus.
  • FIG. 12 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 4 in a compressed conformation in the lumen of a delivery apparatus.
  • FIGS. 13 and 14 are superior views illustrating the use of the disc treatment apparatus of FIG. 11 to release the disc treatment device of FIG. 3 into a disc cavity.
  • FIG. 15 is a perspective view of another disc treatment device of the invention.
  • FIGS. 16-18 illustrate elongate implants of the invention and apparatuses and methods for their introduction into the disc cavity.
  • FIGS. 19-21 illustrate elongate implants of the invention and additional apparatuses and methods for their introduction into the disc cavity.
  • the present invention provides intervertebral disc treatment devices, apparatuses and methods.
  • Preferred devices include a fibrous body configurable to smaller
  • the body In the small configuration the body is adapted for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. In the larger configuration the body is dimensioned sufficiently to resist expulsion from the annulus opening when positioned within the disc cavity.
  • the body incorporates an effective amount of a substance which promotes tissue formation in the disc structure.
  • Inventive apparatuses which include such fibrous bodies in combination with a delivery apparatus adapted to retain and selectively release the bodies into the disc cavities, and inventive methods are also provided can be performed using the devices and apparatuses of the invention.
  • a preferred intervertebral disc treatment device 11 that includes an outer surface 12, and opposing ends 13.
  • Device 11 is elongate in shape, having a generally cylindrical configuration with a circular cross-section.
  • Device 11 has a length L and a cross- sectional dimension adapted for insertion into the disc cavity of a damaged disk.
  • length L will be about equal to or less than a horizontal cross-sectional dimension of the disc cavity of a human disc (e.g. the anterior-posterior width and/or the lateral width of the disc cavity) , typically in the range of about 1.5 cm to about 3.5 cm.
  • device 11 will be of a size and composition so as to avoid the exertion of substantial lateral pressure upon the annulus fibrosis by the device, which may cause or facilitate the development of a rupture in the annulus fibrosis.
  • Device 11 will have or be compressible radially to have a greatest cross- sectional dimension which renders device 11 suited for insertion into an opening in a disc annulus, such greatest cross-sectional dimension typically being in the range of about 0.3 cm to about 2.0 cm.
  • Device 11 may, for instance, have a body comprised of a woven or nonwoven fibrous material, including but not limited to a fibrous mesh.
  • the body of device 11 is also preferably swellable in the presence of aqueous fluids, for example swelling upon absorbing aqueous fluids into pores created between fibers in a fibrous body, and/or upon hydration of the fibers themselves.
  • device 11 may be formed as a roll of a sheet material, for instance a fibrous mesh, to provide a multi-layered device. Uging such a multi- layered configuration, the device may be constructed to prevent, or alternatively to allow, for unrolling or unfolding of the layers after insertion into the disc cavity.
  • layers may be permanently affixed to one another such as by bonding, crosslinking or stitching, to prevent unfolding.
  • layers may be free of permanent affixation to one another (e.g.
  • Such unfolding may, for example, participate in configuring the device to resist expulsion from an annulus fibrosis opening, and/or to occupy a modified volume within the disc cavity for supporting tissue ingrowth.
  • the device may assume a variety of other configurations including spherical, rectangular, conical, ring, and other shapes. It is preferred that the device be shaped so that it can facilitate blocking an opening in the annulus fibrosus of a damaged intervertebral disc when positioned in the disc cavity.
  • the device may have a first end having a cross-sectional dimension smaller than another cross-sectional dimension along the device, for example having an increasing cross-sectional dimension along the device length such as occurs in a generally conical device.
  • such a disc repair device 21 having a generally conical shape with a larger end 22 and an outer surface 23 that tapers towards a smaller opposing end 24.
  • the device may be collapsible in upon itself to have a smaller overall cross-sectional dimension in a direction in which it is to be inserted, for example in the case of an annular ring.
  • Shown in FIG. 4 is such a disc treatment device 31, having the shape of an annular ring.
  • Device 31 preferably has an outer diameter, when expanded, approximating the horizontal width of the disc cavity, and can be collapsed upon itself to adopt a smaller overall cross-sectional dimension for insertion through an opening in the annulus fibrosis.
  • an intervertebral disc 41 includes the annulus fibrosus 42 formed from multiple layers of type II collagenous tissue, bounding an internal disc cavity 43.
  • Disc treatment device 11 is sized and configured to be contained within the disc cavity and in the illustrated embodiment has a vertical dimension to contact the upper and lower surfaces of the disc cavity formed by end plates of adjacent vertebrae.
  • device 11 has a horizontal dimension substantially spanning the horizontal width of the disc cavity 43.
  • Device 11 also abuts the inner surface of the annulus fibrosus 42 so as to facilitate blockage of effluence from disc cavity 43 via opening 44 in annulus fibrosus 42.
  • Opening 44 in annulus fibrosis 42 often occurs posterolaterally, where the annulus fibrosis is no longer supported by the posterior longitudinal ligament.
  • device 11 or other disc treatment devices of the invention can be inserted via a posterolateral approach, although other approaches may be used which correspond to the location of the rupture in the disc to be treated, or which involve insertion of the device through a conservative, alternate opening created in a spaced location from the rupture .
  • FIGS. 6, 7, and 8 shown are superior views of disc treatment devices 11, 21, and 31, respectively, positioned within the disc cavity of a ruptured disc.
  • the disc treatment devices of the invention may be formed from a wide variety of natural and/or synthetic materials, preferably natural and/or synthetic polymers.
  • Natural polymers include, for example, collagen, elastin, and cellulose and may be obtained from natural sources by methods known to the skilled artisan, synthesized by methods known to those skilled in the art, or may be obtained commercially.
  • Synthetic polymers which may be used in the present invention include, for example, polyamides, polyesters (e.g., Dacron) , polyethylene, polyacrylonitrile, polyurethanes, polypropylenes or mixtures thereof. Combinations of natural and synthetic materials may also form an appropriate fibrous body for use in the present invention.
  • the preferred devices of the invention advantageously incorporate a tissue growth factor.
  • the device includes a liquid or solid carrier containing the tissue growth factor.
  • a solid or liquid carrier containing the growth factor may be used to coat the exterior of the device, and/or may be incorporated within interstitial spaces (e.g. pores) occurring internally of the device.
  • a solid carrier matrix containing the growth factor may be used to coat individual fibers from which the body of the disc treatment device is formed.
  • the growth factor is generally suited to promote the formation of tissues, especially of the type(s) naturally occurring as internal or external components of the disc.
  • the growth factor may promote the growth or viability of tissue or cell types occurring in the nucleus pulposus such as nucleus pulposus cells and chondrocytes, as well as space filling cells such as fibrobiasts and connective tissue cells such as ligament and tendon cells.
  • the growth factor may promote the growth or viability of tissue types occurring in the annulus fibrosus, as well as space filling cells such as fibrobiasts and connective tissue cells such as ligament and tendon cells.
  • Such growth factors include Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins, Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs), Cartilage Derived Growth Factors (CDGFs) , Cartilage Derived Morphogenic Proteins (CDMPs), Bone Morphogenetic Proteins (BMPs), and mixtures thereof. BMPs are preferred.
  • TGF-B Transforming Growth Factor-beta
  • FGF Fibroblast Growth Factor
  • PDGF Platelet Derived Growth Factor
  • GDFs Growth Differentiation Factors
  • CDGFs Cartilage Derived Growth Factor
  • BMPs have been identified and may be used in the present invention.
  • Human BMPs especially recombinant human BMPs, are preferred, including for instance BMPs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 and 18.
  • a variety of such BMPs have proven effective for forming soft connective tissues such as cartilage (e.g. BMP-2 and BMP-4) or ligament and tendon (e.g. BMP-12 and BMP-13), and these and other similarly functional proteins are used with preference in the instant invention.
  • BMPs are available from Genetics Institute, Inc., Cambridge, Massachusetts and may also be prepared by one skilled in the art as described in U.S. Patent Nos.
  • the BMP or other growth factor will be non-osteoinductive or at the least insu ficiently osteoinductive to cause, a bony fusion of the vertebrae above and below the disc under treatment.
  • BMP-12 and/or BMP- 13 will be employed in an effective amount to stimulate growth of ligament and/or tendon connective tissue within the disc cavity, for instance as may be evidenced by increased synthesis of proteoglycans and collagens. Recombinant human BMP-13 is most preferred in this regard.
  • the carrier is collagen.
  • types of collagen may be used, including type I (found primarily in skin, tendon and bone), type II (found in cartilage), type III (found primarily in skin), fibrillar and non-fibrillar collagen.
  • the collagen may be isolated from skin, bone, tendon, or cartilage by methods known to the skilled artisan and may be purified by methods known in the art. Alternately, the collagen may be purchased commercially.
  • atelopeptidic or telopeptidic collagen may be used. - 1 !
  • the tissue growth factor may be applied to the device as described above or may be introduced into the disc space or cavity separately (e.g. by injection), or by recombinant DNA methods.
  • a nucleic acid sequence such as a deoxyribonucleic acid sequence, encoding the particular growth factor, or an active fragment thereof, may be introduced into an appropriate vector.
  • the vector may be a wide variety of vectors typically used in gene transfer protocols, including, for example, retroviral vectors or adenovirus vectors.
  • the vector construct may be synthesized by methods known to the skilled artisan.
  • the nucleic acid sequence may be under the control of, and operably linked to, a promoter or other regulatory sequence known in the art.
  • the promoter is preferably one which may be activated in the target cell by regulatory elements present in the target cell.
  • the disc repair device advantageously includes a therapeutically effective amount of the tissue growth factor. What constitutes an effective amount will vary depending on factors known to the skilled artisan, such as the specific growth factor used and the extent and type of the damage to the intervertebral disc. However, the disc repair device will typically contain about 2 mg to about 20 mg of the growth factor. When BMP-9 is used, for example, amounts applied may include about 8 mg to about 12 mg.
  • an intervertebral disc treatment apparatus is provided that includes a disc repair device as described above in combination with a delivery apparatus. Referring now to FIG. 11, apparatus 61 is shown that includes the generally conical disc repair device 21 of FIG. 3, in compressed configuration within the apparatus.
  • the disc treatment apparatus 61 includes ⁇ tubular or barrel member 62 having proximal end, a distal end, and a lumen 63 extending longitudinally therethrough.
  • Member 62 may be similar to the barrel of a syringe as known in 'the art. Lumen 63 is configured for housing the disc repair device. Member 62 may be constructed of a wide variety of materials, including polytetrafiuoroethylene (Teflon) , polyethylene, polyurethane, nylon, glass, or combinations thereof.
  • Teflon polytetrafiuoroethylene
  • Disc repair delivery apparatus 61 further includes a translation member 64 at the proximal end of tubular member 62 for forcing the disc repair device 21 distally through lumen 63, through an opening in the annulus fibrosus of a damaged disc, and into the disc cavity of the disc.
  • Translation member 64 may be an elongated member sized to at least partially fit within lumen 63 of member 62 and which is capable of pushing the disc repair device distally along lumen 63.
  • member 64 may be a plunger including a handle 67, an elongate rod 66, and an internal member 65 substantially spanning the lumen 63 of tubular member 62, as seen in FIG. 8.
  • translation member 64 may be replaced by other means for translating device 21 along lumen 63.
  • the disc repair device such as disc repair device 21, is preferably placed in a collapsed or compressed conformation as shown in FIG. 11, advantageously by manual force, prior to or upon positioning the device 21 in lumen 63 shown in FIG. 12 is a similar disc- treatment apparatus 71 except ⁇ including therein device 31 of FIG. 4 in compressed configuration, instead of device 21 of FIG. 3.
  • a method of treating an intervertebral disc includes providing a disc treatment device as described above, such as a fibrous body sized for introduction into an opening of an annulus fibrosus of a damaged intervertebral disc, and inserting the fibrous body into and through the opening, and blocking effluence from the opening.
  • a disc repair delivery apparatus 61 or 71 as described above may be used. As seen in FIGS.
  • FIG. 14 shown is an alternative disc treatment device 70, having a generally bulbous end 71 and a generally cylindrical end 72. Bulbous end 71 has a greatest cross-sectional diameter greater than that of cylindrical end 72.
  • device 70 can be compressed and loaded into a cylindrical delivery apparatus, and delivered through a hole in the annulus and into the disc cavity, preferably first introducing bulbous end 71. Device 70 can then expand within the disc cavity.
  • an elongate, cylindrical implant 78 is provided (e.g. a Dacron mesh cylinder) having an internal suture 79 or other similar structure running therethrough and tied off or otherwise connected at an end 80 of implant 78.
  • the other end of suture 79 is tied to a curved needle 81.
  • implant 78 can be loaded within a rigid tube 82, with needle 81 and an exposed length of suture 79 extending therefrom.
  • Needle 81 can be passed through opening 75 in annulus 7 6 and into the disc cavity 77, and then back through the annulus 76 at a spaced location from opening 75, for example at an opposite, posterolateral position which can be surgically accessed separately. Suture 79 can then be pulled to in turn pull implant 78 into the disc cavity 77. Suture 79 can then be closely cut or broken so as to partially retract into the annulus .
  • FIG 19 illustrates another apparatus and method for delivering an implant 85, such as a cylindrical Dacron mesh implant, into a disc cavity.
  • Implant 85 is loaded within a rigid cannula tube 86, which in turn is passed through the opening in the annulus.
  • implant 85 can be loaded in a dry or wet state, preferably a dry, compressed state.
  • Implant 85 is then advanced through the tube 86 using push or plunger rod 87, and into the disc cavity. After implantation, a dry implant 85 will hydrate, and preferably swell, in si tu in the disc cavity.
  • the internal surface of the tube 86 and the exterior surface of the rod 87 can be provided with respective cooperating members, such as threads, to assist in controllably advancing implant 85 through the tube 86.
  • the inner surface of tube 86 may bear threads, while the external surface of rod 87 bears corresponding threads. In this fashion, rotation of rod 87 in relation to tube 86 will advance rod 87 through tube 86, thereby pushing implant 85 through tube 86.
  • the implant 85 and/or the internal surface of tube 86 may be coated with a suitable, biocompatible lubricant to reduce the friction between the implant 85 and the tube 86 during the advancement operation.
  • a rigid cannula tube 90 defines an opening such as a slot
  • a friction member 92 is mounted over tube 90 and includes an engaging portion 93 extending into slot 91 so as to provide frictional contact with an implant 94 inside tube 90.
  • implant 94 can be advanced through tube 90 by corresponding advancement of the friction member 92 while its engaging portion 93 frictionally engages implant 94 through slot 91.
  • engaging portion 93 with implant 94 can optionally be facilitated by the presence of teeth 95 (e.g. directional as shown) or other roughened surface features such as grooves or proturbances on the engaging portion 93 of friction member 92, and/or by selection of materials exhibiting a coefficient of friction with the implant suitably high to effectively advance the implant through the tube 90.
  • the frictional engagement of engaging portion 93 with implant 94 may be releasable, for example by constructing a deflectable friction member 92 which in a relaxed state disengages engaging portion 93 from the implant, but in a compressed state (e.g. by manually squeezing) engages engaging portion 93 with the implant 94, or vice versa.
  • a tissue growth factor may be provided on the body of or within the device, separately within the disc space of the intervertebral disc, or both. When included separately in the disc space, the tissue growth factor may be provided within the disc space either before or after the disc repair device is positioned. Injection of an aqueous fluid containing the tissue growth factor into the disc repair device may also facilitate expansion of a hydratable, swellable disc repair device immediately after implantation.
  • the disc repair device may be adapted and dimensional such that when in its expanded or swollen conformation, the device is of a sufficiently large dimension to contact the overlying and underlying endplates, preferably under compression, so as to secure the device in place in the disc cavity and desirably 'dissipate compressive loads from the spine.
  • nucleus pulposus of a damaged intervertebral disc may be removed prior to inserting the device. Moreover, the method may also be followed for preventing escape of the nucleus pulposus from a damaged intervertebral disc, as the disc repair devices of the present invention may act as a plug.
  • a single disc repair device can have its longitudinal axis positioned perpendicular to longitudinal axis of the vertebral column, or two or more devices can be positioned in this manner (e.g. two devices used in a bilateral configuration) .
  • Disc treatment devices may be inserted through pre-existing (e.g. rupture) opening in the annulus fibrosus or they may be inserted through a cut or incised opening.
  • the one or more devices provided to the disc cavity will substantially fill the existing void in the cavity, and may also have a sufficient vertical dimension to contact the upper and lower surfaces within the cavity, for instance so as to be effective to absorb compressive loads of the spine.
  • Delivery apparatuses in accordance with the invention may also be adapted for non- or minimally- invasive delivery of the intervertebral disc treatment device.
  • such an apparatus can include a cannulated device of sufficient length to extend to the disc cavity from an exterior operating position, and the disc treatment device can be advanced (e.g. in compressed or collapsed form) through and out the distal end of the cannula and into the disc cavity.
  • a procedure may immediately follow a known discectomy protocol, including for instance microdiscectomies, endoscopic discectomies, and laparoscopic discectomies.
  • the delivery of the disc treatment device may be conducted under endoscopic or other similar visualization techniques.

Abstract

Intervertebral disc treatment devices and methods are provided. An intervertebral disc treatment device (11) includes a fibrous body sized for introduction into a disc cavity (43) of a damaged disc wherein the body incorporates an effective amount of a tissue growth factor. Intervertebral disc treatment apparatuses are also described that include such a disc treatment device in combination with a delivery apparatus for retaining and selectively releasing the device into the disc cavity (43). Methods for treatment include providing a disc treatment device (11) as described above and inserting the device into an opening (44) in an annulus fibrous (42) and into the disc cavity (43). The methods further include stimulating tissue growth within the disc cavity (43) of the intervertebral disc (41).

Description

INTERVERTEBRAL DISC TREATMENT DEVICES AND METHODS
BACKGROUND OF THE INVENTION
The present invention relates generally to devices and methods for restoring function to the spine. Specifically, the invention relates., to devices and methods for treating a damaged intervertebral disc while retaining the annulus fibrosis of the disc and, advantageously, stimulating tissue formation to restore function to the original disc structure. Back pain affects millions of people and is a common cause of disability for the middle-aged working population. A frequent cause of back pain is rupture or degeneration of intervertebral discs. Intervertebral discs, located between the endplates of adjacent vertebrae, stabilize the spine, distribute forces between vertebrae, and cushion vertebral bodies. An intervertebral disc includes the annulus fibrosus, a structure that surrounds and confines an inner component, the nucleus pulposus. The annulus fibrosis is composed of a ring of collagen fibers and fibrocartilage embedded in a generally amorphous base substance. The nucleus pulposus is comprised of a mucoid material containing mainly glycoproteins and some collagen. In a healthy, undamaged spine, the annulus fibrosus prevents the nucleus pulposus from protruding outside the disc space and also resists torsional and bending forces applied to the disc. Intervertebral discs may be displaced or damaged due to disease or aging. Disruption of the annulus fibrosus can allow the nucleus pulposus to protrude into the vertebral canal or intervertebral foramen, a condition known as a herniated or slipped disc. A rupture in the annulus fibrosis can allow the escape of nucleus pulposus components. The extruded nucleus pulposus may press on a spinal nerve,^ which may result in nerve damage, pain, numbness, muscle weakness and paralysis. Furthermore, as a disc dehydrates and hardens due to age or disease, the disc space height will be reduced, leading to instability of the spine, decreased mobility and pain. Moreover, excessive movement of the spinal segments caused by the disc space height reduction could weaken the annulus fibrosus and, in certain cases, tear it.
Common methods of providing relief for damaged intervertebral discs include surgical removal of all or a portion of the intervertebral disc, followed by fusion of the adjacent vertebrae. Although fusion can eliminate the above symptoms, the restricted motion of the fused segment increases the range of motion required of the adjoining intervertebral discs and could enhance their degeneration. Attempts at overcoming the problems with fusion include replacing the entire intervertebral disc with a mechanical, articulating intervertebral disc spacer.
Many of these devices utilize multicomponent polymeric and metallic materials in an attempt to simulate the normal, healthy intervertebral disc motion. Such materials may disintegrate in the body and break down under repeated stressing over prolonged periods. Other attempts at overcoming the problems with replacing the entire intervertebral disc have included replacing the nucleus pulposus with elastomeric materials such as hydrogels .
SUMMARY OF THE INVENTION
The present invention relates to methods and devices for repairing an intervertebral disc which include promoting synthesis of tissue components, such as nucleus pulposus and/or annulus fibrosus components, of the disc. In one aspect, the present invention provides a device which can be used to promote the synthesis of disc components in vivo to treat intervertebral discs. In particular, provided is a device for treating an intervertebral disc of a vertebrate while retaining an intact annulus fibrosis, the device including a compressible fibrous body configurable to a compressed state for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. The body is also configurable to an expanded state to reside within the disc cavity and have a dimension greater than the opening so as to resist expulsion from the opening. The body incorporates an effective amount of an active agent, such as a tissue growth factor, or cells (e.g. stem, nucleus pulposus, annulus fibrosis, or fibroblast cells) , such cells optionally genetically modified to express effective amounts of a tissue growth factor, to stimulate tissue growth in the disc structure.
Another aspect of the invention provides an intervertebral disc treatment device including a fibrous body sized for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. The body is formed of fibers having coated thereon a solid carrier matrix incorporating a substance for promoting tissue growth.
In the above-discussed aspects of the invention, the body of the device may be partially or completely bioresorbable . In addition, the body may be sized and configured to provide temporary or permanent prosthetic function, by being dimensioned to participate in the distribution of compressive loads between adjacent vertebral bodies. For example, the body may be adapted to physically maintain a space in the disc as new tissue is generated, and provide a substrate ' for tissue ingrowth which locks the implant in place ar.d reinforces regenerated tissues to help maintain disc space height. In another inventive aspect, the body may be non-prosthetic, while delivering a substance for promoting tissue growth in the disc structure. In such non-prosthetic applications, the device can be dimensioned, or can be formed of a material having compressive properties, such that it does not participate in the distribution of loads between the adjacent vertebral bodies. Nonetheless, such a non-prosthetic body may deliver the tissue growth substance so as to enhance the function or integrity of the disc structure. Another feature of the invention provides an intervertebral disc repair apparatus that has a disc treatment device as described above in combination with a delivery apparatus. The delivery apparatus is adapted to retain and selectively release the treatment device into the disc cavity, and may for example include a member having a proximal end, a distal end and a lumen extending longitudinally therethrough. The disc repair device is disposed within the lumen of the apparatus. The delivery apparatus is adapted to translate the disc repair device distally through the lumen, through an opening in the annulus fibrosis, and into the disc cavity.
•.Yet other features of the invention include methods for treating an intervertebral disc, which involve introducing a disc treatment device as described above into the disc cavity of a damaged disc.
In additional embodiments of the invention, methods for treating a disc having an annulus fibrosis having an opening therein, which methods include providing a body configured for passage through the opening and for blocking effluence from the opening once positioned within the disc cavity. The body is passed through the opening and into the disc cavity, so as to block effluence from the opening. A tissue growth composition is also provided within the disc cavity, either as a component of the body or separately.
It is an object of the invention to provide devices and methods that may be used to provide therapy to a damaged disc by promoting in vivo synthesis of components within the disc structure.
It is a further object of the invention to provide methods and devices for preventing effluence from a damaged intervertebral disc. These and other objects and advantages of the present invention will be apparent from the descriDtions herein.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 is a perspective view of a disc treatment device of the present invention. FIG. 2 is an enlarged, cross-sectional view of the device of FIG. 1 taken along a vertical plane through line 2-2 and viewed in the direction of the arrows.
. FIG. 3 is a perspective view of a further disc treatment device of the present invention having an annular ring shape.
FIG. 4 is a perspective view of a further disc treatment ' device of the present invention.
FIG. 5 is a side cross-sectional view illustrating the disc repair device shown in FIG. 1 positioned within an intervertebral disc.
FIG. 6 is a superior view of the disc treatment device of FIG. 1 positioned in the disc cavity of an intervertebral disc.
FIG. 7 is a superior view of the disc treatment device of FIG. 3 positioned in the disc cavity of an intervertebral disc.
FIG. 8 is a superior view of the disc treatment device of FIG. 4 positioned in the disc cavity of an intervertebral disc. FIG. 9 is a superior view illustrating two disc treatment devices positioned in the disc cavity of an intervertebral disc, and wherein an opening in the annulus fibrosis is sealed with a sealant composition. FIG. 10 is a superior view illustrating first and second disc treatment devices positioned within the disc cavity of an intervertebral disc, wherein one functions to seal a rupture in the annulus fibrosis. FIG. 11 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 3 in a compressed conformation in the lumen of a delivery apparatus.
FIG. 12 is a side cross-sectional view of a disc treatment apparatus, showing the disc treatment device of FIG. 4 in a compressed conformation in the lumen of a delivery apparatus.
FIGS. 13 and 14 are superior views illustrating the use of the disc treatment apparatus of FIG. 11 to release the disc treatment device of FIG. 3 into a disc cavity.
FIG. 15 is a perspective view of another disc treatment device of the invention.
FIGS. 16-18 illustrate elongate implants of the invention and apparatuses and methods for their introduction into the disc cavity.
FIGS. 19-21 illustrate elongate implants of the invention and additional apparatuses and methods for their introduction into the disc cavity.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to preferred embodiments thereof and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications of the invention, and such further applications of the principles of the invention as illustrated herein, being contemplated as would normally occur to one skilled in the art to which the invention relates.
The present invention provides intervertebral disc treatment devices, apparatuses and methods. Preferred devices include a fibrous body configurable to smaller
(compressed) and larger (relaxed) dimensional states.
In the small configuration the body is adapted for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis. In the larger configuration the body is dimensioned sufficiently to resist expulsion from the annulus opening when positioned within the disc cavity. The body incorporates an effective amount of a substance which promotes tissue formation in the disc structure.
Inventive apparatuses are provided which include such fibrous bodies in combination with a delivery apparatus adapted to retain and selectively release the bodies into the disc cavities, and inventive methods are also provided can be performed using the devices and apparatuses of the invention.
Referring now to FIG. 1, a preferred intervertebral disc treatment device 11 is illustrated that includes an outer surface 12, and opposing ends 13. Device 11 is elongate in shape, having a generally cylindrical configuration with a circular cross-section. Device 11 has a length L and a cross- sectional dimension adapted for insertion into the disc cavity of a damaged disk. In preferred devices, length L, will be about equal to or less than a horizontal cross-sectional dimension of the disc cavity of a human disc (e.g. the anterior-posterior width and/or the lateral width of the disc cavity) , typically in the range of about 1.5 cm to about 3.5 cm. Preferably also, device 11 will be of a size and composition so as to avoid the exertion of substantial lateral pressure upon the annulus fibrosis by the device, which may cause or facilitate the development of a rupture in the annulus fibrosis. Device 11 will have or be compressible radially to have a greatest cross- sectional dimension which renders device 11 suited for insertion into an opening in a disc annulus, such greatest cross-sectional dimension typically being in the range of about 0.3 cm to about 2.0 cm. Device 11 may, for instance, have a body comprised of a woven or nonwoven fibrous material, including but not limited to a fibrous mesh. The body of device 11 is also preferably swellable in the presence of aqueous fluids, for example swelling upon absorbing aqueous fluids into pores created between fibers in a fibrous body, and/or upon hydration of the fibers themselves.
Referring now to Figure 2, shown is an enlarged, cross-sectional view taken in a vertical plane along line 2-2 of FIG. 1 and viewed in the direction of the arrows. As illustrated, device 11 may be formed as a roll of a sheet material, for instance a fibrous mesh, to provide a multi-layered device. Uging such a multi- layered configuration, the device may be constructed to prevent, or alternatively to allow, for unrolling or unfolding of the layers after insertion into the disc cavity. For instance, layers may be permanently affixed to one another such as by bonding, crosslinking or stitching, to prevent unfolding. On the other hand, layers may be free of permanent affixation to one another (e.g. non-affixed or only temporarily affixed), to allow the layers to unfold within the disc cavity. Such unfolding may, for example, participate in configuring the device to resist expulsion from an annulus fibrosis opening, and/or to occupy a modified volume within the disc cavity for supporting tissue ingrowth.
Although a generally cylindrical disc repair device is shown in FIGS. 1 and 2, the device may assume a variety of other configurations including spherical, rectangular, conical, ring, and other shapes. It is preferred that the device be shaped so that it can facilitate blocking an opening in the annulus fibrosus of a damaged intervertebral disc when positioned in the disc cavity. For example, the device may have a first end having a cross-sectional dimension smaller than another cross-sectional dimension along the device, for example having an increasing cross-sectional dimension along the device length such as occurs in a generally conical device. Referring now to FIG. 3, such a disc repair device 21 is shown, having a generally conical shape with a larger end 22 and an outer surface 23 that tapers towards a smaller opposing end 24. As another example, the device may be collapsible in upon itself to have a smaller overall cross-sectional dimension in a direction in which it is to be inserted, for example in the case of an annular ring. Shown in FIG. 4 is such a disc treatment device 31, having the shape of an annular ring. Device 31 preferably has an outer diameter, when expanded, approximating the horizontal width of the disc cavity, and can be collapsed upon itself to adopt a smaller overall cross-sectional dimension for insertion through an opening in the annulus fibrosis. With reference now to FIG. 5, shown is a side cross-sectional view of a intervertebral disc having positioned therein disc treatment device 11 of FIG. 1. As illustrated, an intervertebral disc 41 includes the annulus fibrosus 42 formed from multiple layers of type II collagenous tissue, bounding an internal disc cavity 43. Disc treatment device 11 is sized and configured to be contained within the disc cavity and in the illustrated embodiment has a vertical dimension to contact the upper and lower surfaces of the disc cavity formed by end plates of adjacent vertebrae. In addition, device 11 has a horizontal dimension substantially spanning the horizontal width of the disc cavity 43. Device 11 also abuts the inner surface of the annulus fibrosus 42 so as to facilitate blockage of effluence from disc cavity 43 via opening 44 in annulus fibrosus 42. Opening 44 in annulus fibrosis 42 often occurs posterolaterally, where the annulus fibrosis is no longer supported by the posterior longitudinal ligament. Thus, in most cases, device 11 or other disc treatment devices of the invention can be inserted via a posterolateral approach, although other approaches may be used which correspond to the location of the rupture in the disc to be treated, or which involve insertion of the device through a conservative, alternate opening created in a spaced location from the rupture .
With reference now to FIGS. 6, 7, and 8, shown are superior views of disc treatment devices 11, 21, and 31, respectively, positioned within the disc cavity of a ruptured disc.
The disc treatment devices of the invention may be formed from a wide variety of natural and/or synthetic materials, preferably natural and/or synthetic polymers. Natural polymers include, for example, collagen, elastin, and cellulose and may be obtained from natural sources by methods known to the skilled artisan, synthesized by methods known to those skilled in the art, or may be obtained commercially. Synthetic polymers which may be used in the present invention include, for example, polyamides, polyesters (e.g., Dacron) , polyethylene, polyacrylonitrile, polyurethanes, polypropylenes or mixtures thereof. Combinations of natural and synthetic materials may also form an appropriate fibrous body for use in the present invention.
The preferred devices of the invention advantageously incorporate a tissue growth factor. In one embodiment, the device includes a liquid or solid carrier containing the tissue growth factor. For example, a solid or liquid carrier containing the growth factor may be used to coat the exterior of the device, and/or may be incorporated within interstitial spaces (e.g. pores) occurring internally of the device. In addition, or alternatively, a solid carrier matrix containing the growth factor may be used to coat individual fibers from which the body of the disc treatment device is formed. The growth factor is generally suited to promote the formation of tissues, especially of the type(s) naturally occurring as internal or external components of the disc. For instance, the growth factor may promote the growth or viability of tissue or cell types occurring in the nucleus pulposus such as nucleus pulposus cells and chondrocytes, as well as space filling cells such as fibrobiasts and connective tissue cells such as ligament and tendon cells. Alternatively or in addition, the growth factor may promote the growth or viability of tissue types occurring in the annulus fibrosus, as well as space filling cells such as fibrobiasts and connective tissue cells such as ligament and tendon cells. Such growth factors include Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins, Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs), Cartilage Derived Growth Factors (CDGFs) , Cartilage Derived Morphogenic Proteins (CDMPs), Bone Morphogenetic Proteins (BMPs), and mixtures thereof. BMPs are preferred.
A wide variety of BMPs have been identified and may be used in the present invention. Human BMPs, especially recombinant human BMPs, are preferred, including for instance BMPs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 and 18. A variety of such BMPs have proven effective for forming soft connective tissues such as cartilage (e.g. BMP-2 and BMP-4) or ligament and tendon (e.g. BMP-12 and BMP-13), and these and other similarly functional proteins are used with preference in the instant invention. BMPs are available from Genetics Institute, Inc., Cambridge, Massachusetts and may also be prepared by one skilled in the art as described in U.S. Patent Nos. 5,187,076 to Wozney et al.; 5,366,875 to Wozney et al.; 4,877,864 to Wang et al.; 5,108,932 to Wang et al.; 5,116,738 to Wang et al.; 5,013,649 to Wang et al.; 5,106,748 to Wozney et al; and PCT Patent Nos. WO93/00432 to Wozney et al.; W094/2693 to Celeste et al.; and W094/26892 to Celeste et al. All BMPs are contemplated whether obtained as above or isolated from bone. Methods for isolating BMP from bone are described in U.S. Patent no. 4,294,753 to Urist and in Urist et al . , PNAS 371, 1984. Most preferably, the BMP or other growth factor will be non-osteoinductive or at the least insu ficiently osteoinductive to cause, a bony fusion of the vertebrae above and below the disc under treatment. In one aspect of the invention, BMP-12 and/or BMP- 13 will be employed in an effective amount to stimulate growth of ligament and/or tendon connective tissue within the disc cavity, for instance as may be evidenced by increased synthesis of proteoglycans and collagens. Recombinant human BMP-13 is most preferred in this regard.
A wide variety of materials may be utilized as solid carriers. Examples include natural polymers such as collagen, gelatin, elastin, cellulose, and the like. In one preferred embodiment, the carrier is collagen. A wide variety of types of collagen may be used, including type I (found primarily in skin, tendon and bone), type II (found in cartilage), type III (found primarily in skin), fibrillar and non-fibrillar collagen. The collagen may be isolated from skin, bone, tendon, or cartilage by methods known to the skilled artisan and may be purified by methods known in the art. Alternately, the collagen may be purchased commercially. Moreover, atelopeptidic or telopeptidic collagen may be used. - 1 !
In methods for disc treatment, the tissue growth factor may be applied to the device as described above or may be introduced into the disc space or cavity separately (e.g. by injection), or by recombinant DNA methods. For example, a nucleic acid sequence, such as a deoxyribonucleic acid sequence, encoding the particular growth factor, or an active fragment thereof, may be introduced into an appropriate vector. The vector may be a wide variety of vectors typically used in gene transfer protocols, including, for example, retroviral vectors or adenovirus vectors. The vector construct may be synthesized by methods known to the skilled artisan. The nucleic acid sequence may be under the control of, and operably linked to, a promoter or other regulatory sequence known in the art. The promoter is preferably one which may be activated in the target cell by regulatory elements present in the target cell.
In one form of the invention, the disc repair device advantageously includes a therapeutically effective amount of the tissue growth factor. What constitutes an effective amount will vary depending on factors known to the skilled artisan, such as the specific growth factor used and the extent and type of the damage to the intervertebral disc. However, the disc repair device will typically contain about 2 mg to about 20 mg of the growth factor. When BMP-9 is used, for example, amounts applied may include about 8 mg to about 12 mg. In another aspect of the invention, an intervertebral disc treatment apparatus is provided that includes a disc repair device as described above in combination with a delivery apparatus. Referring now to FIG. 11, apparatus 61 is shown that includes the generally conical disc repair device 21 of FIG. 3, in compressed configuration within the apparatus. The disc treatment apparatus 61 includes ^tubular or barrel member 62 having proximal end, a distal end, and a lumen 63 extending longitudinally therethrough.
Member 62 may be similar to the barrel of a syringe as known in 'the art. Lumen 63 is configured for housing the disc repair device. Member 62 may be constructed of a wide variety of materials, including polytetrafiuoroethylene (Teflon) , polyethylene, polyurethane, nylon, glass, or combinations thereof.
Disc repair delivery apparatus 61 further includes a translation member 64 at the proximal end of tubular member 62 for forcing the disc repair device 21 distally through lumen 63, through an opening in the annulus fibrosus of a damaged disc, and into the disc cavity of the disc. Translation member 64 may be an elongated member sized to at least partially fit within lumen 63 of member 62 and which is capable of pushing the disc repair device distally along lumen 63. For example, member 64 may be a plunger including a handle 67, an elongate rod 66, and an internal member 65 substantially spanning the lumen 63 of tubular member 62, as seen in FIG. 8. Alternately, translation member 64 may be replaced by other means for translating device 21 along lumen 63. For example fluid (e.g. liquid) driven mechanisms may be used. The disc repair device, such as disc repair device 21, is preferably placed in a collapsed or compressed conformation as shown in FIG. 11, advantageously by manual force, prior to or upon positioning the device 21 in lumen 63 shown in FIG. 12 is a similar disc- treatment apparatus 71 except ^including therein device 31 of FIG. 4 in compressed configuration, instead of device 21 of FIG. 3.
In another aspect of the invention, methods of treating 'an intervertebral disc are provided. In one embodiment, a method of treating an intervertebral disc includes providing a disc treatment device as described above, such as a fibrous body sized for introduction into an opening of an annulus fibrosus of a damaged intervertebral disc, and inserting the fibrous body into and through the opening, and blocking effluence from the opening. In order to place the disc repair device in the disc cavity, a disc repair delivery apparatus 61 or 71 as described above may be used. As seen in FIGS. 13 and 14, lumen 63 of tubular member 62 is aligned with the opening in the annulus fibrosus of an intervertebral disc so that the disc repair device may be pushed distally along lumen 63, through the opening in the annulus and into the disc cavity. The disc repair device will then adopt an expanded conformation as seen in FIG. 14. Referring now to Figure 15, shown is an alternative disc treatment device 70, having a generally bulbous end 71 and a generally cylindrical end 72. Bulbous end 71 has a greatest cross-sectional diameter greater than that of cylindrical end 72. In one mode of use, device 70 can be compressed and loaded into a cylindrical delivery apparatus, and delivered through a hole in the annulus and into the disc cavity, preferably first introducing bulbous end 71. Device 70 can then expand within the disc cavity.
With reference now to Figures 16-18, illustrated is one mdde of introducing an elongate implant body through an opening 75 in an annulus 76 (e.g. in the location of a rupture opening) , and into the disc cavity 77. An elongate, cylindrical implant 78 is provided (e.g. a Dacron mesh cylinder) having an internal suture 79 or other similar structure running therethrough and tied off or otherwise connected at an end 80 of implant 78. The other end of suture 79 is tied to a curved needle 81. To deliver the implant 78, implant 78 can be loaded within a rigid tube 82, with needle 81 and an exposed length of suture 79 extending therefrom. Needle 81 can be passed through opening 75 in annulus 76 and into the disc cavity 77, and then back through the annulus 76 at a spaced location from opening 75, for example at an opposite, posterolateral position which can be surgically accessed separately. Suture 79 can then be pulled to in turn pull implant 78 into the disc cavity 77. Suture 79 can then be closely cut or broken so as to partially retract into the annulus .
Figure 19 illustrates another apparatus and method for delivering an implant 85, such as a cylindrical Dacron mesh implant, into a disc cavity. Implant 85 is loaded within a rigid cannula tube 86, which in turn is passed through the opening in the annulus. In this regard, implant 85 can be loaded in a dry or wet state, preferably a dry, compressed state. Implant 85 is then advanced through the tube 86 using push or plunger rod 87, and into the disc cavity. After implantation, a dry implant 85 will hydrate, and preferably swell, in si tu in the disc cavity. If desired, the internal surface of the tube 86 and the exterior surface of the rod 87 can be provided with respective cooperating members, such as threads, to assist in controllably advancing implant 85 through the tube 86. For example, the inner surface of tube 86 may bear threads, while the external surface of rod 87 bears corresponding threads. In this fashion, rotation of rod 87 in relation to tube 86 will advance rod 87 through tube 86, thereby pushing implant 85 through tube 86. In addition, or in the alternative, the implant 85 and/or the internal surface of tube 86 may be coated with a suitable, biocompatible lubricant to reduce the friction between the implant 85 and the tube 86 during the advancement operation.
Referring now to Figures 20 and 21, shown is another apparatus and method for delivering an implant through an annulus opening and into the disc cavity. A rigid cannula tube 90 defines an opening such as a slot
91 in a sidewall thereof. A plurality of openings
(e.g. opposed slots) may also be provided. A friction member 92 is mounted over tube 90 and includes an engaging portion 93 extending into slot 91 so as to provide frictional contact with an implant 94 inside tube 90. In this fashion, implant 94 can be advanced through tube 90 by corresponding advancement of the friction member 92 while its engaging portion 93 frictionally engages implant 94 through slot 91. In this regard, the frictional engagement of the implant
94 can optionally be facilitated by the presence of teeth 95 (e.g. directional as shown) or other roughened surface features such as grooves or proturbances on the engaging portion 93 of friction member 92, and/or by selection of materials exhibiting a coefficient of friction with the implant suitably high to effectively advance the implant through the tube 90. Further, the frictional engagement of engaging portion 93 with implant 94 may be releasable, for example by constructing a deflectable friction member 92 which in a relaxed state disengages engaging portion 93 from the implant, but in a compressed state (e.g. by manually squeezing) engages engaging portion 93 with the implant 94, or vice versa.
A tissue growth factor may be provided on the body of or within the device, separately within the disc space of the intervertebral disc, or both. When included separately in the disc space, the tissue growth factor may be provided within the disc space either before or after the disc repair device is positioned. Injection of an aqueous fluid containing the tissue growth factor into the disc repair device may also facilitate expansion of a hydratable, swellable disc repair device immediately after implantation. The disc repair device may be adapted and dimensional such that when in its expanded or swollen conformation, the device is of a sufficiently large dimension to contact the overlying and underlying endplates, preferably under compression, so as to secure the device in place in the disc cavity and desirably 'dissipate compressive loads from the spine.
All or a portion of the nucleus pulposus of a damaged intervertebral disc may be removed prior to inserting the device. Moreover, the method may also be followed for preventing escape of the nucleus pulposus from a damaged intervertebral disc, as the disc repair devices of the present invention may act as a plug.
It will be understood that various ways of orienting a disc repair device of the present invention in disc cavity are contemplated in the invention. A single disc repair device can have its longitudinal axis positioned perpendicular to longitudinal axis of the vertebral column, or two or more devices can be positioned in this manner (e.g. two devices used in a bilateral configuration) .
Disc treatment devices may be inserted through pre-existing (e.g. rupture) opening in the annulus fibrosus or they may be inserted through a cut or incised opening. In one preferred manner of carrying out the invention, the one or more devices provided to the disc cavity will substantially fill the existing void in the cavity, and may also have a sufficient vertical dimension to contact the upper and lower surfaces within the cavity, for instance so as to be effective to absorb compressive loads of the spine.
Delivery apparatuses in accordance with the invention may also be adapted for non- or minimally- invasive delivery of the intervertebral disc treatment device. For example, such an apparatus can include a cannulated device of sufficient length to extend to the disc cavity from an exterior operating position, and the disc treatment device can be advanced (e.g. in compressed or collapsed form) through and out the distal end of the cannula and into the disc cavity. For example, such a procedure may immediately follow a known discectomy protocol, including for instance microdiscectomies, endoscopic discectomies, and laparoscopic discectomies. Further, the delivery of the disc treatment device may be conducted under endoscopic or other similar visualization techniques.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected. In addition, all references cited herein are indicative of the level of skill in the art and are hereby incorporated by reference ,in their entirety.

Claims

CLAIMSWhat is claimed is:
1. An intervertebral disc treatment device for treating an intervertebral disc of a vertebrate while retaining an intact annulus fibrosis, comprising: a compressible fibrous body configurable to a compressed state for passage through an opening in the annulus fibrosis and into a disc cavity defined by the annulus fibrosis; said body configurable to an expanded state to reside within the disc cavity and have a dimension greater than said opening so as to resist expulsion from said opening; and said body incorporating an effective amount of a tissue growth factor.
2. The device of claim 1, wherein said fibrous body comprises synthetic fibers.
3. The device of claim 2, wherein said synthetic fibers comprise a material selected from the group consisting of polyamides, polyesters, polyethylenes, polyacrylonitriles, polyurethanes, polypropyler.es and mixtures thereof.
4. The device of claim 2, wherein said synthetic fibers comprise polyester. - 2 \
5. The device of claim 1, wherein said fibrous body is comprised of fibers coated with a solid carrier matrix comprising the tissue growth factor.
5 6. The device of claim 1, wherein said fibrous body is comprised of natural fibers.
7. The device of claim 6, wherein said natural fibers are collagen.
10
8. ,The device of claim 6, wherein said natural fibers are elastin.
9. The device of claim 1, wherein said body 15 incorporates a tissue growth composition comprising a tissue growth factor within a biocompatible carrier.
10. The device of claim 9, wherein said tissue growth composition is incorporated within said body.
20
11. The device of claim 9, wherein said tissue growth composition is bound to an exterior surface of said body.
25 12. The device of claim 11, wherein said biocompatible carrier comprises a polymer.
13. The device of claim 12, wherein said polymer is a naturally occurring polymer.
14. The device of claim 12, wherein said polymer is collagen.
15. The device of claim 9, wherein said tissue growth factor is selected from the group consisting of
Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins (Ils), Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs) , Cartilage Derived Growth Factors (CDGFs) , Cartilage Derived Morphogenic Proteins (CDMPs) , Bone Morphogenetic Proteins (BMPs), and mixtures thereof.
16. The device of claim 9, wherein said tissue growth factor is a Bone Morphogenetic Protein.
17. The device of claim 15 or 16, wherein said tissue growth factor is a recombinant human protein.
18. The device of claim 16, wherein said bone morphogenetic protein is selected from the group consisting of BMP-1, BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-8, BMP-9, BMP-10, BMP-11, BMP-12, BMP-13, BMP-14, BMP-15, BMP-16, BMP-17, BMP-18, and mixtures or heterodimers thereof.
19. The device of claim 1, wherein said fibrous body is a multi-layered body.
20. The device of claim 1, wherein said body is cylindrical .
21. An intervertebral disc ^ repair device, comprising a mesh sized for introduction into a disc cavity, said mesh incorporating an effective amount of a tissue growth factor to promote tissue growth within the disc cavity.
22. The device of claim 21, wherein said mesh is comprised of synthetic fibers.
23. The device of claim 22, wherein said synthetic fibers comprise a material selected from the group consisting of polyamides, polyesters, polyacrylonitrile, polyurethanes, polypropylene and mixtures thereof.
24. The device of claim 22, wherein said synthetic fibers comprise polyester.
25. The device of claim 21, wherein said mesh is comprised of natural fibers.
26. The device of claim 25, wherein said natural fibers are selected from the group consisting of elastin and collagen.
27. The device of claim 21, which incorporates a tissue growth composition including the tissue growth factor and a biocompatible carrier.
28. The device of claim 27, wherein said tissue growth factor is selected from the group consisting of Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins (Ils), Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs), Cartilage Derived Growth Factors (CDGFs) , Cartilage Derived Morphogenic Proteins (CDMPs), Bone Morphogenetic Proteins (BMPs), and mixtures thereof.
29. The device of claim 27, wherein said tissue growth factor is a bone morphogenetic protein.
30. The device of claim 27, wherein said biocompatible carrier includes a natural or synthetic polymer.
31. An intervertebral disc repair device, comprising a bioresorbable body sized for introduction into a disc cavity, said body incorporating an effective amount of a tissue growth factor.
32. The device of claim 31, wherein said bioresorbable body is comprised of natural fibers.
33. The device of claim 32, wherein said natural fibers are selected from the group consisting of elastin aηd collagen.
34. The device of claim 31, which incorporates a tissue growth composition including a tissue growth factor and a biocompatible carrier.
35. The device of claim 34, wherein said tissue growth factor is selected from the group consisting of Transforming Growth Factor-beta (TGF-B) and members of the TGF-B superfamily, Fibroblast Growth Factor (FGF) and members of the FGF family, Platelet Derived Growth Factor (PDGF) and members of the PDGF family, members of the hedgehog family of proteins, interleukins (Ils), Insulin-like Growth Factor (IGF) and members of the IGF family, colony-stimulating factor (CSF) and members of the CSF family, Growth Differentiation Factors (GDFs) , Cartilage Derived Growth Factors (CDGFs), Cartilage Derived Morphogenic Proteins (CDMPs) , Bone Morphogenetic Proteins (BMPs), and mixtures thereof.
36. The device of claim 34, wherein said tissue growth factor is a bone morphogenetic protein.
37. The device of claim 34, wherein said biocompatible carrier includes a natural or synthetic polymer.
38. An apparatus for treating an intervertebral disc, comprising:
(a) a disc treatment device comprising a fibrous body sized for introduction into a disc cavity of a damaged disc, said body incorporating an effective amount of a tissue growth factor; and (b) a delivery apparatus adapted to retain and selectively release the disc treatment device into the disc cavity.
39. The apparatus of claim 38, wherein said delivery apparatus comprises: a member having a proximal end, a distal end and a lumen extending longitudinally therethrough, said disc treatment device disposed in said lumen; and means at the proximal end of said member for forcing said disc treatment device distally through said lumen and into said disc cavity of said damaged disc.
40. A method for treating an intervertebral disc, comprising: (a) providing a fibrous body sized for introduction into a disc cavity of a damaged disc;
(b) introducing said fibrous body into the disc cavity of said intervertebral disc through an opening in said disc; and
(c) providing a tissue growth factor within the disc cavity of said intervertebral disc.
41. The method of claim 40, wherein said body is in a compressed configuration prior to said introducing, and expands within the disc cavity after said introducing.
42. The method of claim 40, including sealing said opening after said introducing.
43. The method of claim 40, comprising removing a portion of the nucleus pulposus of said disc prior to said introducing.
44. The method of claim 40, wherein said tissue growth factor is combined with a biocompatible carrier.
45. Tne method of claim 44, wherein said tissue growth factor stimulates the formation of nucleus pulposus, annulus, ligament, tendon and/or fibroblast cells .
46. The method of claim 40, wherein said tissue growth factor is non-osteogenic.
47. The method of claim 40, wherein said fibrous body is bioresorbable.
48. A method of treating an intervertebral disc, comprising introducing a fibrous body into a disc cavity of a damaged disc between adjacent vertebrae, said body incorporating an effective amount of a tissue growth composition to stimulate soft tissue formation within the disc cavity sufficient to accommodate at least a portion of compressive loads occurring between the adjacent vertebrae.
49. The method of claim 48, wherein said fibrous body is comprised of synthetic fibers.
50. A method of treating an intervertebral disc, comprising:
(a) providing a fibrous body sized for introduction into an opening of an annulus fibrosus of said disc;
(b) inserting said fibrous body through said opening, said body thereby blocking effluence from said opening; and (c) providing a tissue growth composition within the disc space of said intervertebral disc.
51. The method of claim 50, wherein said fibrous body is comprised of synthetic fibers.
52. A method of preventing effluence from a disc cavity of a damaged intervertebral disc having an annulus Fibrosus having an opening, said method comprising inserting a fibrous plug into the cavity of said disc so as to block effluence from said opening.
53. The method of claim 52, wherein said plug comprises an effective amount of a tissue growth composition to stimulate disc repair.
54. A method for treating a damaged intervertebral disc, comprising:
(a) providing an opening in an annulus fibrosis of the damaged intervertebral disc;
(b) passing a non-prosthetic delivery body through said opening and into a disc cavity defined by the annulus fibrosis, the delivery body incorporating a tissue growth factor; and (c) the delivery body releasing the tissue growth factor in the disc cavity and promoting tissue growth in the disc cavity.
55. A method for treating a damaged intervertebral disc in a vertebrate, the intervertebral disc having an annulus fibrosis having a rupture opening, the method comprising introducing a tissue growth factor into a disc cavity of the ruptured intervertebral disc, and sealing the rupture opening of the annulus with a sealant device.
56. A method of treating an intervertebral disc, comprising: introducing a load-bearing, polyester implant into an opening of an annulus fibrosus of said disc.
PCT/US2000/042610 1999-12-06 2000-12-06 Intervertebral disc treatment devices and methods WO2001045577A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002392721A CA2392721C (en) 1999-12-06 2000-12-06 Intervertebral disc treatment devices and methods
EP00992392A EP1244388B1 (en) 1999-12-06 2000-12-06 Intervertebral disc treatment device
DE60033055T DE60033055D1 (en) 1999-12-06 2000-12-06 LUMBAR TREATMENT DEVICE
AU43099/01A AU774481B2 (en) 1999-12-06 2000-12-06 Intervertebral disc treatment devices and methods
JP2001546319A JP4672947B2 (en) 1999-12-06 2000-12-06 Intervertebral disc treatment apparatus and method
DK00992392T DK1244388T3 (en) 1999-12-06 2000-12-06 Device for treating intervertebral discs
US10/165,347 US20020173851A1 (en) 1999-12-06 2002-06-06 Intervertebral disc treatment devices and methods
US10/990,823 US7318840B2 (en) 1999-12-06 2004-11-17 Intervertebral disc treatment devices and methods
US11/877,235 US8349012B2 (en) 1999-12-06 2007-10-23 Intervertebral disc treatment devices and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16914899P 1999-12-06 1999-12-06
US60/169,148 1999-12-06

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US10165347 A-371-Of-International 2000-12-06
US10/165,347 Division US20020173851A1 (en) 1999-12-06 2002-06-06 Intervertebral disc treatment devices and methods
US10/165,347 Continuation US20020173851A1 (en) 1999-12-06 2002-06-06 Intervertebral disc treatment devices and methods
US10/990,823 Continuation US7318840B2 (en) 1999-12-06 2004-11-17 Intervertebral disc treatment devices and methods

Publications (3)

Publication Number Publication Date
WO2001045577A2 true WO2001045577A2 (en) 2001-06-28
WO2001045577A3 WO2001045577A3 (en) 2002-07-11
WO2001045577A9 WO2001045577A9 (en) 2002-12-05

Family

ID=22614410

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/042610 WO2001045577A2 (en) 1999-12-06 2000-12-06 Intervertebral disc treatment devices and methods

Country Status (9)

Country Link
US (3) US20020173851A1 (en)
EP (1) EP1244388B1 (en)
JP (1) JP4672947B2 (en)
AU (1) AU774481B2 (en)
CA (1) CA2392721C (en)
DE (1) DE60033055D1 (en)
DK (1) DK1244388T3 (en)
ES (1) ES2278648T3 (en)
WO (1) WO2001045577A2 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002017824A2 (en) * 2000-08-30 2002-03-07 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US6508839B1 (en) 1999-08-18 2003-01-21 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
WO2003020169A2 (en) * 2001-08-30 2003-03-13 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
EP1562524A2 (en) * 2002-11-05 2005-08-17 Spineology, Inc. A semi-biological intervertebral disc replacement system
FR2866227A1 (en) * 2004-02-17 2005-08-19 Frederic Fortin Intervertebral annulus prosthesis, has shape of ring, made of monoblock deformable viscoelastic material, with fixing unit connected to connection rod and permitting rod to be pushed in intervertebral cavity where it is compressed
US6936072B2 (en) 1999-08-18 2005-08-30 Intrinsic Therapeutics, Inc. Encapsulated intervertebral disc prosthesis and methods of manufacture
WO2005089679A1 (en) * 2004-02-17 2005-09-29 Frederic Fortin Intervertebral annulus prosthesis
WO2006092015A1 (en) * 2005-03-01 2006-09-08 Columna Pty Ltd Intervertebral disc restoration
US7144397B2 (en) 2000-08-18 2006-12-05 Intrinsic Therapeutics, Inc. Minimally invasive system for manipulating intervertebral disc tissue
US7169405B2 (en) 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US7198047B2 (en) 1999-08-18 2007-04-03 Intrinsic Therapeutics, Inc. Anchored anulus method
EP1954215A2 (en) * 2005-11-21 2008-08-13 Nicast Ltd. Spinal nucleus prosthesis device
US7749275B2 (en) 1999-08-18 2010-07-06 Intrinsic Therapeutics, Inc. Method of reducing spinal implant migration
US7753933B2 (en) 2000-12-14 2010-07-13 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US7771414B2 (en) 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US7846208B2 (en) 1999-10-20 2010-12-07 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US7879027B2 (en) 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US8057510B2 (en) 2000-12-14 2011-11-15 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US8075587B2 (en) 2000-12-14 2011-12-13 Ensure Medical, Inc. Apparatus and methods for sealing vascular punctures
US8088144B2 (en) 2005-05-04 2012-01-03 Ensure Medical, Inc. Locator and closure device and method of use
US8579934B2 (en) 2003-10-17 2013-11-12 Ensure Medical, Inc. Locator and delivery device and method of use
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US8642060B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8852229B2 (en) 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
US8926654B2 (en) 2005-05-04 2015-01-06 Cordis Corporation Locator and closure device and method of use
US9039741B2 (en) 2005-12-28 2015-05-26 Intrinsic Therapeutics, Inc. Bone anchor systems
US20160220638A1 (en) * 2006-10-06 2016-08-04 Scil Technology Gmbh Spinal nucleus pulposus implant
US9492148B2 (en) 2000-12-14 2016-11-15 CARDINAL HEALTH SWITZERLAND 515 GmbH Apparatus and methods for sealing vascular punctures
US9655602B2 (en) 2000-12-14 2017-05-23 CARDINAL HEALTH SWITZERLAND 515 GmbH Vascular plug having composite construction
US9675347B2 (en) 1999-10-20 2017-06-13 Krt Investors, Inc. Apparatus for the treatment of tissue
US9706947B2 (en) 1999-08-18 2017-07-18 Intrinsic Therapeutics, Inc. Method of performing an anchor implantation procedure within a disc
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
US9795372B2 (en) 2010-01-11 2017-10-24 Krt Investors, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
US9867714B1 (en) 2011-09-23 2018-01-16 Samy Abdou Spinal fixation devices and methods of use
US10076424B2 (en) 2007-09-07 2018-09-18 Intrinsic Therapeutics, Inc. Impaction systems
US10111757B2 (en) 2012-10-22 2018-10-30 Cogent Spine, LLC Devices and methods for spinal stabilization and instrumentation
US10179012B2 (en) 2013-01-28 2019-01-15 Cartiva, Inc. Systems and methods for orthopedic repair
US10245018B2 (en) 2006-06-13 2019-04-02 Suture Concepts Inc. Method and apparatus for closing fissures in the annulus fibrosus
US10327907B2 (en) 1999-05-28 2019-06-25 Suture Concepts Inc. Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
CN110719765A (en) * 2017-06-05 2020-01-21 奥萨克斯有限公司 Implantable tissue repair device and method of making same
US10543107B2 (en) 2009-12-07 2020-01-28 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US10548740B1 (en) 2016-10-25 2020-02-04 Samy Abdou Devices and methods for vertebral bone realignment
US10695105B2 (en) 2012-08-28 2020-06-30 Samy Abdou Spinal fixation devices and methods of use
US10857003B1 (en) 2015-10-14 2020-12-08 Samy Abdou Devices and methods for vertebral stabilization
US10918498B2 (en) 2004-11-24 2021-02-16 Samy Abdou Devices and methods for inter-vertebral orthopedic device placement
US10973648B1 (en) 2016-10-25 2021-04-13 Samy Abdou Devices and methods for vertebral bone realignment
US11006982B2 (en) 2012-02-22 2021-05-18 Samy Abdou Spinous process fixation devices and methods of use
US11179248B2 (en) 2018-10-02 2021-11-23 Samy Abdou Devices and methods for spinal implantation

Families Citing this family (172)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20060247665A1 (en) 1999-05-28 2006-11-02 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US7273497B2 (en) 1999-05-28 2007-09-25 Anova Corp. Methods for treating a defect in the annulus fibrosis
WO2009033100A1 (en) 2007-09-07 2009-03-12 Intrinsic Therapeutics, Inc. Bone anchoring systems
US7553329B2 (en) * 1999-08-18 2009-06-30 Intrinsic Therapeutics, Inc. Stabilized intervertebral disc barrier
EP1624832A4 (en) * 1999-08-18 2008-12-24 Intrinsic Therapeutics Inc Devices and method for augmenting a vertebral disc nucleus
US7998213B2 (en) * 1999-08-18 2011-08-16 Intrinsic Therapeutics, Inc. Intervertebral disc herniation repair
US20040010317A1 (en) * 1999-08-18 2004-01-15 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US8128698B2 (en) 1999-10-20 2012-03-06 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7004970B2 (en) 1999-10-20 2006-02-28 Anulex Technologies, Inc. Methods and devices for spinal disc annulus reconstruction and repair
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7744599B2 (en) 2000-02-16 2010-06-29 Trans1 Inc. Articulating spinal implant
US6805695B2 (en) 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
US7204851B2 (en) * 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
DE60232893D1 (en) 2001-10-02 2009-08-20 Rex Medical Lp EDDY IMPLANT
CN1774220A (en) 2003-02-14 2006-05-17 德普伊斯派尔公司 In-situ formed intervertebral fusion device and method
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
DK1638485T3 (en) * 2003-06-20 2011-05-02 Intrinsic Therapeutics Inc Device for delivery of an implant through an annular defect in an intervertebral disc
JP2007516738A (en) 2003-10-23 2007-06-28 トランスワン インコーポレイティッド Tools and tool kits for minimal intrusion processing on the spine
US7763077B2 (en) * 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US20050209602A1 (en) * 2004-03-22 2005-09-22 Disc Dynamics, Inc. Multi-stage biomaterial injection system for spinal implants
ATE506919T1 (en) * 2004-03-26 2011-05-15 Nuvasive Inc DISC PROSTHESIS
EP2298335B1 (en) * 2004-05-25 2014-09-03 Stryker Corporation Use of OP-1 for treating cartilage defects
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20060074422A1 (en) * 2004-09-27 2006-04-06 Story Brooks J Suture anchor and void filler combination
WO2006050493A2 (en) * 2004-11-03 2006-05-11 The Regents Of The University Of Michigan Biodegradable implant for intertransverse process fusion
AU2005316274A1 (en) * 2004-12-16 2006-06-22 Replication Medical, Inc. Radially compressed dehydrated spinal nucleus implants
US8702718B2 (en) 2005-04-29 2014-04-22 Jmea Corporation Implantation system for tissue repair
US7632313B2 (en) 2005-04-29 2009-12-15 Jmea Corporation Disc repair system
US8162992B2 (en) * 2005-04-30 2012-04-24 Warsaw Orthopedic, Inc. Spinal fusion with osteogenic material and migration barrier
WO2006119455A1 (en) * 2005-05-03 2006-11-09 Yeung Jeffrey E Injection device for the intervertebral disc
US20070049849A1 (en) * 2005-05-24 2007-03-01 Schwardt Jeffrey D Bone probe apparatus and method of use
US7601172B2 (en) * 2005-06-15 2009-10-13 Ouroboros Medical, Inc. Mechanical apparatus and method for artificial disc replacement
US7547319B2 (en) * 2005-06-15 2009-06-16 Ouroboros Medical Mechanical apparatus and method for artificial disc replacement
US7442210B2 (en) 2005-06-15 2008-10-28 Jerome Segal Mechanical apparatus and method for artificial disc replacement
US8021426B2 (en) 2005-06-15 2011-09-20 Ouroboros Medical, Inc. Mechanical apparatus and method for artificial disc replacement
US20070162135A1 (en) * 2005-06-15 2007-07-12 Jerome Segal Mechanical apparatus and method for artificial disc replacement
US7988735B2 (en) * 2005-06-15 2011-08-02 Matthew Yurek Mechanical apparatus and method for delivering materials into the inter-vertebral body space for nucleus replacement
US8092548B2 (en) 2005-06-22 2012-01-10 Warsaw Orthopedic, Inc. Osteograft treatment to promote osteoinduction and osteograft incorporation
AU2006279558B2 (en) 2005-08-16 2012-05-17 Izi Medical Products, Llc Spinal tissue distraction devices
US8591583B2 (en) 2005-08-16 2013-11-26 Benvenue Medical, Inc. Devices for treating the spine
US8366773B2 (en) 2005-08-16 2013-02-05 Benvenue Medical, Inc. Apparatus and method for treating bone
US20070093905A1 (en) * 2005-10-21 2007-04-26 O'neil Michael J Degenerative disc regeneration techniques
US8236055B2 (en) * 2005-12-16 2012-08-07 Seaspine, Inc. Intervertebral prosthesis for supporting adjacent vertebral bodies enabling the creation of soft fusion and method
US7613426B2 (en) 2005-12-20 2009-11-03 Microsoft Corporation Proximity service discovery in wireless networks
US8559350B2 (en) * 2005-12-20 2013-10-15 Microsoft Corporation Mechanism to convey discovery information in a wireless network
US8478300B2 (en) * 2005-12-20 2013-07-02 Microsoft Corporation Proximity service discovery in wireless networks
US7988695B2 (en) 2005-12-21 2011-08-02 Theken Spine, Llc Articulated delivery instrument
US20070161962A1 (en) * 2006-01-09 2007-07-12 Edie Jason A Device and method for moving fill material to an implant
WO2007087718A1 (en) * 2006-02-01 2007-08-09 Bonegrafix Inc. Bioimplants for use in tissue growth
CA2637029C (en) * 2006-02-04 2014-03-25 Aleeva Medical, Inc. U-shaped disc-shunt and delivery device
US20070270970A1 (en) * 2006-03-14 2007-11-22 Sdgi Holdings, Inc. Spinal implants with improved wear resistance
US7976549B2 (en) 2006-03-23 2011-07-12 Theken Spine, Llc Instruments for delivering spinal implants
US7993404B2 (en) * 2006-03-29 2011-08-09 Warsaw Orthopedic, Inc. Transformable spinal implants and methods of use
US20070233246A1 (en) * 2006-03-31 2007-10-04 Sdgi Holdings, Inc. Spinal implants with improved mechanical response
US10681151B2 (en) 2006-05-15 2020-06-09 Microsoft Technology Licensing, Llc Notification framework for wireless networks
US8834496B2 (en) 2006-06-13 2014-09-16 Bret A. Ferree Soft tissue repair methods and apparatus
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US7758649B2 (en) * 2006-08-04 2010-07-20 Integrity Intellect Inc. Reversibly deformable implant
US8506636B2 (en) 2006-09-08 2013-08-13 Theken Spine, Llc Offset radius lordosis
US20080065218A1 (en) * 2006-09-13 2008-03-13 O'neil Michael J Annulus fibrosus repair devices and techniques
US20080077241A1 (en) * 2006-09-22 2008-03-27 Linh Nguyen Removable rasp/trial member insert, kit and method of use
US20080172126A1 (en) * 2006-10-03 2008-07-17 Reynolds Martin A Nucleus pulposus injection devices and methods
CA2668655A1 (en) 2006-11-16 2008-05-29 Rex Medical, L.P. Spinal implant and method of use
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7718616B2 (en) * 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8808382B2 (en) * 2006-12-22 2014-08-19 Pioneer Surgical Technology, Inc. Implant retention device and method
CA2678006C (en) 2007-02-21 2014-10-14 Benvenue Medical, Inc. Devices for treating the spine
WO2008101300A1 (en) * 2007-02-23 2008-08-28 Cellixe Pty Ltd Composition and method for the treatment or prevention of spinal disorders
US20080249529A1 (en) * 2007-03-15 2008-10-09 Depuy Spine, Inc. Dual incision disc repair device and method
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
US8681691B2 (en) 2007-07-25 2014-03-25 Microsoft Corporation Base station initiated proximity service discovery and connection establishment
US8092541B2 (en) * 2007-08-03 2012-01-10 Warsaw Orthopedic, Inc. Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
CN101801405A (en) 2007-08-07 2010-08-11 先进科技及再生医学有限责任公司 Be contained in the protein formulations of the GDF-5 in the acidic aqueous solution
US8282681B2 (en) 2007-08-13 2012-10-09 Nuvasive, Inc. Bioresorbable spinal implant and related methods
EP2471493A1 (en) 2008-01-17 2012-07-04 Synthes GmbH An expandable intervertebral implant and associated method of manufacturing the same
US9105031B2 (en) 2008-02-22 2015-08-11 Microsoft Technology Licensing, Llc Authentication mechanisms for wireless networks
US8377135B1 (en) 2008-03-31 2013-02-19 Nuvasive, Inc. Textile-based surgical implant and related methods
WO2009124291A2 (en) * 2008-04-04 2009-10-08 Thomas Haider Patents Intervertebral prostheses with compliant filler material for supporting adjacent vertebral bodies and method
CA2720580A1 (en) 2008-04-05 2009-10-08 Synthes Usa, Llc Expandable intervertebral implant
JP5599778B2 (en) * 2008-04-14 2014-10-01 デピュイ・シンセス・プロダクツ・エルエルシー Liquid buffered GDF-5 formulation
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
US20090263443A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedics, Inc. Methods for treating post-operative effects such as spasticity and shivering with clondine
US8883768B2 (en) * 2008-04-18 2014-11-11 Warsaw Orthopedic, Inc. Fluocinolone implants to protect against undesirable bone and cartilage destruction
US9289409B2 (en) * 2008-04-18 2016-03-22 Warsaw Orthopedic, Inc. Sulindac formulations in a biodegradable material
US8956636B2 (en) 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprosing ketorolac
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US9125917B2 (en) 2008-04-18 2015-09-08 Warsaw Orthopedic, Inc. Fluocinolone formulations in a biodegradable polymer carrier
US20090263451A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
US9132085B2 (en) * 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US8956641B2 (en) 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8629172B2 (en) 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
TW200950839A (en) * 2008-05-13 2009-12-16 Kci Licensing Inc Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin
US8557271B2 (en) * 2008-07-16 2013-10-15 Warsaw Orthopedic, Inc. Drug depot implantable within a joint
US20100015049A1 (en) * 2008-07-16 2010-01-21 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
US9492375B2 (en) * 2008-07-23 2016-11-15 Warsaw Orthopedic, Inc. Foam carrier for bone grafting
US20100057114A1 (en) * 2008-09-02 2010-03-04 Butler Michael S PEEK Spinal Mesh and PEEK Spinal Mesh Applicator
WO2010030933A1 (en) * 2008-09-12 2010-03-18 Articulinx, Inc. Tether-based orthopedic joint device delivery methods
US8163022B2 (en) 2008-10-14 2012-04-24 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US9623222B2 (en) * 2008-10-30 2017-04-18 Warsaw Orthopedic, Inc. Drug depot with anchor
US8980317B2 (en) * 2008-12-23 2015-03-17 Warsaw Orthopedic, Inc. Methods and compositions for treating infections comprising a local anesthetic
US20100228097A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Methods and compositions to diagnose pain
US20100226959A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Matrix that prolongs growth factor release
US8535327B2 (en) 2009-03-17 2013-09-17 Benvenue Medical, Inc. Delivery apparatus for use with implantable medical devices
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US8617583B2 (en) 2009-07-17 2013-12-31 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US8653029B2 (en) 2009-07-30 2014-02-18 Warsaw Orthopedic, Inc. Flowable paste and putty bone void filler
US8231891B2 (en) 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US8211126B2 (en) 2009-09-22 2012-07-03 Jmea Corporation Tissue repair system
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
US8597192B2 (en) 2009-10-30 2013-12-03 Warsaw Orthopedic, Inc. Ultrasonic devices and methods to diagnose pain generators
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8758791B2 (en) * 2010-01-26 2014-06-24 Warsaw Orthopedic, Inc. Highly compression resistant matrix with porous skeleton
US8475824B2 (en) * 2010-01-26 2013-07-02 Warsaw Orthopedic, Inc. Resorbable matrix having elongated particles
US9486500B2 (en) 2010-01-28 2016-11-08 Warsaw Orthopedic, Inc. Osteoimplant and methods for making
US20110184284A1 (en) * 2010-01-28 2011-07-28 Warsaw Orthopedic, Inc. Non-invasive devices and methods to diagnose pain generators
US9050274B2 (en) * 2010-01-28 2015-06-09 Warsaw Orthopedic, Inc. Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
US9125902B2 (en) * 2010-01-28 2015-09-08 Warsaw Orthopedic, Inc. Methods for treating an intervertebral disc using local analgesics
WO2011146614A1 (en) * 2010-05-19 2011-11-24 Transmed7, Llc Methods and apparatus for in situ formation of surgical implants
US9592063B2 (en) 2010-06-24 2017-03-14 DePuy Synthes Products, Inc. Universal trial for lateral cages
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
TW201215379A (en) 2010-06-29 2012-04-16 Synthes Gmbh Distractible intervertebral implant
US8449490B2 (en) * 2010-09-11 2013-05-28 Aleeva Medical Inc. Disc shunt delivery with stepped needle
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8404268B2 (en) 2010-10-26 2013-03-26 Kyphon Sarl Locally targeted anti-fibrotic agents and methods of use
US9414930B2 (en) 2010-10-26 2016-08-16 Kyphon SÀRL Activatable devices containing a chemonucleolysis agent
US8740982B2 (en) 2010-10-26 2014-06-03 Kyphon Sarl Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
WO2012075451A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
WO2012075447A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
US9060978B2 (en) 2011-01-24 2015-06-23 Warsaw Orthopedic, Inc. Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
US9717779B2 (en) 2011-01-31 2017-08-01 Warsaw Orthopedic, Inc. Implantable matrix having optimum ligand concentrations
US9592243B2 (en) 2011-04-25 2017-03-14 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for treatment of an injury
US9511077B2 (en) 2011-04-25 2016-12-06 Warsaw Orthopedic, Inc. Medical devices and methods comprising an anabolic agent for wound healing
WO2012178018A2 (en) 2011-06-24 2012-12-27 Benvenue Medical, Inc. Devices and methods for treating bone tissue
US8758806B2 (en) 2012-01-23 2014-06-24 Warsaw Orthopedic, Inc. Human lubrication gel
US9511018B2 (en) 2012-04-05 2016-12-06 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable matrix
US8993978B2 (en) 2012-05-04 2015-03-31 Honeywell International Inc. Method for assessing an alpha particle emission potential of A metallic material
RU2014146705A (en) 2012-05-29 2016-07-20 ЭнЭлТи-СПАЙН ЛТД. Laterally variable implant
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
US10070969B2 (en) 2013-01-17 2018-09-11 Stryker European Holdings I, Llc Annulus plug for intervertebral disc repair
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US9913728B2 (en) 2013-03-14 2018-03-13 Quandary Medical, Llc Spinal implants and implantation system
US10085783B2 (en) 2013-03-14 2018-10-02 Izi Medical Products, Llc Devices and methods for treating bone tissue
CN104068924B (en) * 2014-01-20 2016-03-30 首都医科大学附属北京朝阳医院 The knee joint cavity implantation device of Zhi Liao popliteal cyst
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
WO2016109555A1 (en) 2014-12-29 2016-07-07 Bioventus, Llc Systems and methods for improved delivery of osteoinductive molecules in bone repair
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
USD802756S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
JP7023877B2 (en) 2016-06-28 2022-02-22 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー Expandable and angle-adjustable range-of-motion intervertebral cage
CN109688981A (en) 2016-06-28 2019-04-26 Eit 新兴移植技术股份有限公司 Distensible, adjustable angle intervertebral cage
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US11213402B2 (en) 2017-01-11 2022-01-04 Loubert S. Suddaby Endoscopically implantable inflatable interbody fusion device
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353936A1 (en) * 1987-08-20 1990-02-07 RayMedica, Inc. Prosthetic disc containing therapeutic material
DE3922203C1 (en) * 1989-07-06 1990-10-25 Martin Nolde Surgical instrument for the implantation of an intervertebral disc core prosthesis
EP0700671A1 (en) * 1994-09-08 1996-03-13 Howmedica Inc. Hydrogel intervertebral disc nucleus
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
WO1998040111A1 (en) * 1997-03-07 1998-09-17 University College London Tissue implant
WO1999061084A1 (en) * 1998-05-29 1999-12-02 Advanced Bio Surfaces, Inc. Implantable tissue repair device
WO1999062439A1 (en) * 1998-06-04 1999-12-09 Raymedica, Inc. Tapered prosthetic spinal disc nucleus
WO2000064385A1 (en) * 1999-04-26 2000-11-02 Li Medical Technologies, Inc. Prosthetic apparatus and method

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294753A (en) 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5366875A (en) 1986-07-01 1994-11-22 Genetics Institute, Inc. Methods for producing BMP-7 proteins
US5108438A (en) * 1989-03-02 1992-04-28 Regen Corporation Prosthetic intervertebral disc
AT393326B (en) 1988-08-02 1991-09-25 Avl Verbrennungskraft Messtech INDICATOR SUBSTANCE FOR A MEASURING DEVICE FOR THE OPTICAL DETERMINATION OF INTERESTING PARAMETERS OF A SAMPLE AND MEASURING PROCEDURE THEREFOR
US5192326A (en) * 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
KR100255415B1 (en) 1991-06-25 2000-05-01 브루스 엠. 에이센 Bone morphogenetic protein-9 compositions
DE4224285C2 (en) 1992-07-23 1995-09-21 Rolf Goldschmidt Support structure for supporting flat components
US5534028A (en) * 1993-04-20 1996-07-09 Howmedica, Inc. Hydrogel intervertebral disc nucleus with diminished lateral bulging
WO1994026892A1 (en) 1993-05-12 1994-11-24 Genetics Institute, Inc. Bmp-11 compositions
US5522898A (en) * 1993-09-16 1996-06-04 Howmedica Inc. Dehydration of hydrogels
US5514180A (en) * 1994-01-14 1996-05-07 Heggeness; Michael H. Prosthetic intervertebral devices
AU2621295A (en) * 1994-05-24 1995-12-18 Smith & Nephew Plc Intervertebral disc implant
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
DK2111876T3 (en) 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Crosslinked polymer preparations and methods for their use
US5645597A (en) * 1995-12-29 1997-07-08 Krapiva; Pavel I. Disc replacement method and apparatus
US6054229A (en) * 1996-07-19 2000-04-25 Ztek Corporation System for electric generation, heating, cooling, and ventilation
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
EP1056413A4 (en) 1998-02-27 2003-08-20 Bioelastics Res Ltd Injectable implants for tissue augmentation and restoration
US20010055594A1 (en) * 1998-09-25 2001-12-27 Kjell Olmarker Use of certain drugs for treating nerve root injury
SE9803710L (en) * 1998-09-25 2000-03-26 A & Science Invest Ab Use of certain substances for the treatment of nerve root damage
US6958149B2 (en) * 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
US20010006948A1 (en) * 1998-11-25 2001-07-05 James D. Kang Gene transfer to intervertebral disc cells
US6419944B2 (en) * 1999-02-24 2002-07-16 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
US6428576B1 (en) 1999-04-16 2002-08-06 Endospine, Ltd. System for repairing inter-vertebral discs
US6419704B1 (en) * 1999-10-08 2002-07-16 Bret Ferree Artificial intervertebral disc replacement methods and apparatus
SE9902155L (en) 1999-06-09 2000-12-10 Bjoern Rydevik Serum antibodies
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
US6723335B1 (en) 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
WO2002000142A2 (en) 2000-06-29 2002-01-03 Mount Sinai Hospital Intervertebral disc

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353936A1 (en) * 1987-08-20 1990-02-07 RayMedica, Inc. Prosthetic disc containing therapeutic material
DE3922203C1 (en) * 1989-07-06 1990-10-25 Martin Nolde Surgical instrument for the implantation of an intervertebral disc core prosthesis
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
EP0700671A1 (en) * 1994-09-08 1996-03-13 Howmedica Inc. Hydrogel intervertebral disc nucleus
WO1998040111A1 (en) * 1997-03-07 1998-09-17 University College London Tissue implant
WO1999061084A1 (en) * 1998-05-29 1999-12-02 Advanced Bio Surfaces, Inc. Implantable tissue repair device
WO1999062439A1 (en) * 1998-06-04 1999-12-09 Raymedica, Inc. Tapered prosthetic spinal disc nucleus
WO2000064385A1 (en) * 1999-04-26 2000-11-02 Li Medical Technologies, Inc. Prosthetic apparatus and method

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10327907B2 (en) 1999-05-28 2019-06-25 Suture Concepts Inc. Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US6936072B2 (en) 1999-08-18 2005-08-30 Intrinsic Therapeutics, Inc. Encapsulated intervertebral disc prosthesis and methods of manufacture
US6508839B1 (en) 1999-08-18 2003-01-21 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
US7198047B2 (en) 1999-08-18 2007-04-03 Intrinsic Therapeutics, Inc. Anchored anulus method
US7749275B2 (en) 1999-08-18 2010-07-06 Intrinsic Therapeutics, Inc. Method of reducing spinal implant migration
US8002836B2 (en) 1999-08-18 2011-08-23 Intrinsic Therapeutics, Inc. Method for the treatment of the intervertebral disc anulus
US9706947B2 (en) 1999-08-18 2017-07-18 Intrinsic Therapeutics, Inc. Method of performing an anchor implantation procedure within a disc
US9675347B2 (en) 1999-10-20 2017-06-13 Krt Investors, Inc. Apparatus for the treatment of tissue
US7670380B2 (en) 1999-10-20 2010-03-02 Anulex Technologies, Inc. Intervertebral disc annulus stent
US7846208B2 (en) 1999-10-20 2010-12-07 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US7144397B2 (en) 2000-08-18 2006-12-05 Intrinsic Therapeutics, Inc. Minimally invasive system for manipulating intervertebral disc tissue
EP1563808A1 (en) * 2000-08-30 2005-08-17 SDGI Holdings, Inc. Intervertebral disc nucleus implants
WO2002017824A3 (en) * 2000-08-30 2003-03-06 Sdgi Holdings Inc Intervertebral disc nucleus implants and methods
WO2002017824A2 (en) * 2000-08-30 2002-03-07 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US8409248B2 (en) 2000-12-14 2013-04-02 Core Medical, Inc. Plug with detachable guidewire element and methods for use
US8075587B2 (en) 2000-12-14 2011-12-13 Ensure Medical, Inc. Apparatus and methods for sealing vascular punctures
US7753933B2 (en) 2000-12-14 2010-07-13 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US9655602B2 (en) 2000-12-14 2017-05-23 CARDINAL HEALTH SWITZERLAND 515 GmbH Vascular plug having composite construction
US9492148B2 (en) 2000-12-14 2016-11-15 CARDINAL HEALTH SWITZERLAND 515 GmbH Apparatus and methods for sealing vascular punctures
US8057510B2 (en) 2000-12-14 2011-11-15 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US8888812B2 (en) 2000-12-14 2014-11-18 Cordis Corporation Plug with collet and apparatus and methods for delivering such plugs
WO2003020169A3 (en) * 2001-08-30 2004-03-04 Sdgi Holdings Inc Intervertebral disc nucleus implants and methods
WO2003020169A2 (en) * 2001-08-30 2003-03-13 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
EP1562524A2 (en) * 2002-11-05 2005-08-17 Spineology, Inc. A semi-biological intervertebral disc replacement system
EP1562524A4 (en) * 2002-11-05 2010-12-22 Spineology Inc A semi-biological intervertebral disc replacement system
US8012211B2 (en) 2002-11-05 2011-09-06 Spineology, Inc. Semi-biological intervertebral disc replacement system
US9061064B2 (en) 2003-08-06 2015-06-23 Warsaw Orthopedic, Inc. Implantable devices for chemonucleolysis of intervertebral discs
US8920828B2 (en) 2003-08-06 2014-12-30 Warsaw Orthopedic, Inc. Implants for treatment of symptomatic or degenerated intervertebral discs
US7169405B2 (en) 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US8579934B2 (en) 2003-10-17 2013-11-12 Ensure Medical, Inc. Locator and delivery device and method of use
US8852229B2 (en) 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
FR2866227A1 (en) * 2004-02-17 2005-08-19 Frederic Fortin Intervertebral annulus prosthesis, has shape of ring, made of monoblock deformable viscoelastic material, with fixing unit connected to connection rod and permitting rod to be pushed in intervertebral cavity where it is compressed
WO2005089679A1 (en) * 2004-02-17 2005-09-29 Frederic Fortin Intervertebral annulus prosthesis
US10918498B2 (en) 2004-11-24 2021-02-16 Samy Abdou Devices and methods for inter-vertebral orthopedic device placement
US11096799B2 (en) 2004-11-24 2021-08-24 Samy Abdou Devices and methods for inter-vertebral orthopedic device placement
WO2006092015A1 (en) * 2005-03-01 2006-09-08 Columna Pty Ltd Intervertebral disc restoration
US8088144B2 (en) 2005-05-04 2012-01-03 Ensure Medical, Inc. Locator and closure device and method of use
US8926654B2 (en) 2005-05-04 2015-01-06 Cordis Corporation Locator and closure device and method of use
US9289198B2 (en) 2005-05-04 2016-03-22 Cordis Corporation Locator and closure device and method of use
EP1954215A4 (en) * 2005-11-21 2012-12-19 Nicast Ltd Spinal nucleus prosthesis device
EP1954215A2 (en) * 2005-11-21 2008-08-13 Nicast Ltd. Spinal nucleus prosthesis device
US9610106B2 (en) 2005-12-28 2017-04-04 Intrinsic Therapeutics, Inc. Bone anchor systems
US9039741B2 (en) 2005-12-28 2015-05-26 Intrinsic Therapeutics, Inc. Bone anchor systems
US11185354B2 (en) 2005-12-28 2021-11-30 Intrinsic Therapeutics, Inc. Bone anchor delivery systems and methods
US10470804B2 (en) 2005-12-28 2019-11-12 Intrinsic Therapeutics, Inc. Bone anchor delivery systems and methods
US8642060B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7771414B2 (en) 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US7879027B2 (en) 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US10245018B2 (en) 2006-06-13 2019-04-02 Suture Concepts Inc. Method and apparatus for closing fissures in the annulus fibrosus
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US20160220638A1 (en) * 2006-10-06 2016-08-04 Scil Technology Gmbh Spinal nucleus pulposus implant
US10076424B2 (en) 2007-09-07 2018-09-18 Intrinsic Therapeutics, Inc. Impaction systems
US10716685B2 (en) 2007-09-07 2020-07-21 Intrinsic Therapeutics, Inc. Bone anchor delivery systems
US10610380B2 (en) 2009-12-07 2020-04-07 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US10857004B2 (en) 2009-12-07 2020-12-08 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US11918486B2 (en) 2009-12-07 2024-03-05 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US10543107B2 (en) 2009-12-07 2020-01-28 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US10945861B2 (en) 2009-12-07 2021-03-16 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US9795372B2 (en) 2010-01-11 2017-10-24 Krt Investors, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
US11324608B2 (en) 2011-09-23 2022-05-10 Samy Abdou Spinal fixation devices and methods of use
US9901458B1 (en) 2011-09-23 2018-02-27 Samy Abdou Spinal fixation devices and methods of use
US9867714B1 (en) 2011-09-23 2018-01-16 Samy Abdou Spinal fixation devices and methods of use
US10575961B1 (en) 2011-09-23 2020-03-03 Samy Abdou Spinal fixation devices and methods of use
US11517449B2 (en) 2011-09-23 2022-12-06 Samy Abdou Spinal fixation devices and methods of use
US11839413B2 (en) 2012-02-22 2023-12-12 Samy Abdou Spinous process fixation devices and methods of use
US11006982B2 (en) 2012-02-22 2021-05-18 Samy Abdou Spinous process fixation devices and methods of use
US10695105B2 (en) 2012-08-28 2020-06-30 Samy Abdou Spinal fixation devices and methods of use
US11559336B2 (en) 2012-08-28 2023-01-24 Samy Abdou Spinal fixation devices and methods of use
US11173040B2 (en) 2012-10-22 2021-11-16 Cogent Spine, LLC Devices and methods for spinal stabilization and instrumentation
US10111757B2 (en) 2012-10-22 2018-10-30 Cogent Spine, LLC Devices and methods for spinal stabilization and instrumentation
US11918483B2 (en) 2012-10-22 2024-03-05 Cogent Spine Llc Devices and methods for spinal stabilization and instrumentation
US11471199B2 (en) 2013-01-28 2022-10-18 Cartiva, Inc. Systems and methods for orthopedic repair
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
US10179012B2 (en) 2013-01-28 2019-01-15 Cartiva, Inc. Systems and methods for orthopedic repair
US10857003B1 (en) 2015-10-14 2020-12-08 Samy Abdou Devices and methods for vertebral stabilization
US11246718B2 (en) 2015-10-14 2022-02-15 Samy Abdou Devices and methods for vertebral stabilization
US11259935B1 (en) 2016-10-25 2022-03-01 Samy Abdou Devices and methods for vertebral bone realignment
US10548740B1 (en) 2016-10-25 2020-02-04 Samy Abdou Devices and methods for vertebral bone realignment
US11058548B1 (en) 2016-10-25 2021-07-13 Samy Abdou Devices and methods for vertebral bone realignment
US10744000B1 (en) 2016-10-25 2020-08-18 Samy Abdou Devices and methods for vertebral bone realignment
US11752008B1 (en) 2016-10-25 2023-09-12 Samy Abdou Devices and methods for vertebral bone realignment
US10973648B1 (en) 2016-10-25 2021-04-13 Samy Abdou Devices and methods for vertebral bone realignment
CN110719765A (en) * 2017-06-05 2020-01-21 奥萨克斯有限公司 Implantable tissue repair device and method of making same
US11179248B2 (en) 2018-10-02 2021-11-23 Samy Abdou Devices and methods for spinal implantation

Also Published As

Publication number Publication date
CA2392721C (en) 2009-01-20
US20020173851A1 (en) 2002-11-21
WO2001045577A3 (en) 2002-07-11
US7318840B2 (en) 2008-01-15
EP1244388A2 (en) 2002-10-02
AU774481B2 (en) 2004-07-01
US8349012B2 (en) 2013-01-08
CA2392721A1 (en) 2001-06-28
DK1244388T3 (en) 2007-05-14
WO2001045577A9 (en) 2002-12-05
US20060004456A1 (en) 2006-01-05
JP2003518021A (en) 2003-06-03
JP4672947B2 (en) 2011-04-20
ES2278648T3 (en) 2007-08-16
EP1244388B1 (en) 2007-01-17
AU4309901A (en) 2001-07-03
DE60033055D1 (en) 2007-03-08
US20080114458A1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
EP1244388B1 (en) Intervertebral disc treatment device
US11491023B2 (en) Methods and apparatus for minimally invasive modular interbody fusion devices
US7524333B2 (en) Method of anchoring an implant in an intervertebral disc
US7998213B2 (en) Intervertebral disc herniation repair
US7658765B2 (en) Resilient intervertebral disc implant
US8157863B2 (en) Devices, apparatus, and methods for bilateral approach to disc augmentation
EP0353936B1 (en) Prosthetic disc containing therapeutic material
US20090222096A1 (en) Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
US20120316648A1 (en) Intervertebral disc reinforcement systems
US20030114930A1 (en) Apparatus and method to stabilize and repair an intervertebral disc
US20070255286A1 (en) Devices, apparatus, and methods for improved disc augmentation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 43099/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2392721

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 546319

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000992392

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000992392

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWG Wipo information: grant in national office

Ref document number: 43099/01

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2000992392

Country of ref document: EP